Top Stories of the Month: Why China Still Doesn’t Have an mRNA Shot
Caixin Global’s Top Stories of the Month newsletter brings you the most popular news coverage over the past month. You can opt-in now and get handpicked news coverage delivered to your inbox each month for free.
As the rapidly mutating coronavirus drives a surge of global investment into vaccine development, Chinese companies are scrambling to catch up with overseas competitors in producing powerful shots, despite their technological shortfalls in developing mRNA-based Covid vaccines.
- MOST POPULAR